Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Keith Kaye

General ID · RU

View

Dr. Rochelle Walensky

General ID · Harvard Medical School

View

Dr. Erin Bonura

General ID · OHSU

View

Dr. Nizar Wehbi

General ID

View

Dr. Robert Schooley

General ID · UCSD

View

Dr. Priya Nori

General ID · MMC

View

Dr. Jan Patterson

General ID · UTHSCSA

View

Dr. Kavita Bhavan

General ID · Dallas County Hospital District

View

Dr. John Goldman

General ID · UPMC Central PA

View

Dr. Gonzalo Bearman

General ID · Medical College of Virginia

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    RNDr. Richard Nathan

    Dr. Richard Nathan

    Infectious Disease · General Infectious Disease
    Idaho Falls Community Hospital
    richardn

    Research

    Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI

    2024

    Via Infectious Diseases and Therapy

    Research

    Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial

    2023

    Via JAMA Network Open

    Research

    Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach

    2023

    Via The Journal of Allergy and Clinical Immunology

    Research

    Recurrent Clostridioides difficile infection worsens anxiety-related patient-reported quality of life

    2022

    Via J Patient Rep Outcomes

    Research

    Appropriate cleaning reduces potential risk of spore transmission from patients with Clostridioides difficile infection treated in outpatient infusion centers

    2022

    Via Anaerobe

    Research

    Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer

    2020

    Via Open Forum Infectious Diseases

    Research

    Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study

    2017

    Via The Lancet Infectious Diseases

    Research

    Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

    2017

    Via New England Journal of Medicine

    Research

    Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial

    2016

    Via Vaccine

    Research

    Efficacy of high-dose versus standard-dose influenza vaccine in older adults

    2014

    Via New England Journal of Medicine

    Research

    Extremely low excretion of daptomycin into breast milk of a nursing mother with methicillin-resistant Staphylococcus aureus pelvic inflammatory disease

    2009

    Via Pharmacotherapy